
News|Articles|April 1, 2007
First-time generic approvals
A discussion of generic drugs recently approved by FDA
Advertisement
Key Points
Ranitidine oral solution, 15 mg/mL (equiv to Zantac syrup)
ACTAVIS
Didanosine for oral solution, 10 mg/mL (equiv to Videx Pediatric Powder for oral solution)
AUROBINDO
Moexipril/hydrochlorothiazide tablets, 12.5/7.5 mg, 25/15 mg, and 12.5/15 mg (equiv to Uniretic tablets)
TEVA
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
New cholesterol guideline expands treatment eligibility to 55% of U.S. adults
2
500,000 Medicaid beneficiaries with diabetes to lose coverage by 2034
3
Ashley Holzworth-Nash, Pharm.D., Evernorth
4
Adalimumab grabs top spot as most cost-efficient biologic for hidradenitis suppurativa
5




















